生活方式干预对门诊慢性非萎缩性胃炎伴糜烂的疗效影响.docVIP

精品论文 参考文献 生活方式干预对门诊慢性非萎缩性胃炎伴糜烂的疗效影响 （1.南京军区南京总医院消化内科 江苏 南京 210002；2.75600部队 广东 深圳 518048） 【摘 要】目的：探讨改变生活方式对门诊慢性非萎缩性胃炎伴糜烂的疗效影响；方法：2014年2月至2015年2月收治的门诊慢性非萎缩性胃炎伴糜烂患者共40例，临床表现为上腹痛、饱胀、嗳气明显，胃镜检查确诊慢性非萎缩性胃炎伴糜烂。随机分为2组，对照组（20例）给予奥美拉唑胶囊、多潘立酮片口服，干预组（20例）给予奥美拉唑胶囊、多潘立酮片口服同时对患者进行生活方式干预，疗程均为2周。随访并记录两组治疗后第3天、第1周、第2周的临床症状，同时对比两组治疗前、治疗2周后的内镜表现。结果：治疗第3天总有效率干预组（70.0%）显著高于对照组（30.0%），差异有统计学意义（P＜0.05）；治疗第1周总有效率干预组（95.0%）显著高于对照组（75.0%），差异有统计学意义（P＜0.05）；治疗第2周总有效率干预组（100.0%）高于对照组（90.0%），差异无统计学意义（P＞0.05）。治疗第2周复查内镜发现总有效率干预组（100.0%）显著高于对照组（90.0%），差异有统计学意义（P＜0.05）。结论：生活方式干预能明显加快缓解慢性非萎缩性胃炎伴糜烂患者的临床症状，缩短疗程，并能显著改善内镜表现。 【关键词】生活方式；慢性非萎缩性胃炎；糜烂 【中图分类号】R197 【文献标识码】A 【文章编号】1004-6194（2015）02-0197-02 Efficacy of lifestyle therapeutics in treating chronic non-atrophic gastritis complicated with erosion WAN Hai-Jun1、2,YUAN Bo-Si1,LU Heng1,WU Lin1,WANG Zhen-Kai1,WEI Juan1,LIU Jiong1,LU You-Ke1,WANG Fang-Yu1* （1 Department of Gastroenterology，General Hospital of Nanjing Military Command，PLA，Nanjing, 210002； 2 No.75600 Military Hospital，PLA，Shenzhen, 518048） 【Abstract】Objective：To investigate the efficacy of lifestyle therapeutics in treating chronic non-atrophic gastritis complicated with erosion. Methods：40 endoscope diagnosed chronic non-atrophic gastritis accompanying with erosion cases were divided at random into 2 groups：The control group(20 cases)was only treated with omeprazole capsules and domperidone tablets,and the treatment group (20 cases )was treated with the two medicine and lifestyle therapeutics simultaneously.The treatment went on for 2 weeks. Several symptoms and endoscope features were recorded before and after the treatment，and compared between the two groups. Results：Significant improvement of clinical symptoms was observed between the two groups．The total rate of response in the treatment group was 70.0％ vs 30.0％ in the control group after three dayrsquo;s therapy (Plt;0.05)；The total rate of response in the treatment group was 95.0％ vs 75.0％ in the control group a